MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$706K
Net Income
-$31,643K
Net Profit Margin
-4482.01%
EPS
-$0.55
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Collaboration revenue
706
-
Research and development
24,149
25,945
General and administrative
10,661
9,875
Total operating expenses
34,810
35,820
Loss from operations
-34,104
-35,820
Interest and investment income
2,498
2,889
Other expense, net
-37
-121
Total other income, net
2,461
2,768
Net loss
-31,643
-33,052
Basic EPS
-0.55
-0.57
Diluted EPS
-0.55
-0.57
Basic Average Shares
58,005,928
58,005,312
Diluted Average Shares
58,005,928
58,005,312
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest and investment
income
$2,498K
Net loss
-$31,643K
Total other income,
net
$2,461K
Other expense, net
-$37K
Loss from operations
-$34,104K
Collaboration revenue
$706K
Total operating
expenses
$34,810K
Research and development
$24,149K
General and
administrative
$10,661K
Buy us a coffee
Astria Therapeutics, Inc. (ATXS)
Astria Therapeutics, Inc. (ATXS)